Cytokinetics, Incorporated
IT ˙ BIT ˙ US23282W6057
62,32 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityIT:1CYTK / Cytokinetics, Incorporated
InstitutionPoint72 Asset Management, L.P.
ManagerSteven Cohen
Latest Disclosed Ownership1,176,653 shares
Ownership 1.70%
Point72 Asset Management, L.P. ownership in 1CYTK / Cytokinetics, Incorporated

2021-02-16 - Point72 Asset Management, L.P. has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,176,653 shares of Cytokinetics, Incorporated (IT:1CYTK). This represents 1.7 percent ownership of the company. In their previous filing dated 2020-02-14 , Point72 Asset Management, L.P. had reported owning 3,031,849 shares, indicating a decrease of -61.19 percent.

Point72 Asset Management, L.P. has a history of taking positions in derivatives of the underlying security (1CYTK) in the form of stock options. The firm currently holds call options representing 28,000 of underlying shares valued at $1,845,480 USD and put options representing 6,900 of underlying shares valued at $454,779 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2021-02-16 2021-02-16 13G/A 3,031,849 1,176,653 -61.19 1.70 -66.67
2020-02-14 2020-02-14 13G/A 2,985,508 3,031,849 1.55 5.10 2.00
2019-12-27 2019-12-27 13G 0 2,985,508 5.00
2015-02-17 2015-02-17 13G/A 0 0.00

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IT:1CYTK / Cytokinetics, Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CYTOKINETICS COM NEW 23282W605 626,102 626,102 41,266 0.0529
2026-02-17 2025-12-31 13F CYTOKINETICS COM NEW 23282W605 0 -471,482 -100.00 0 -100.00
2025-11-14 2025-09-30 13F CYTOKINETICS COM NEW 23282W605 471,482 471,482 25,913 0.0434
2025-08-14 2025-06-30 13F CYTOKINETICS COM NEW 23282W605 0 -1,722,984 -100.00 0 -100.00
2025-07-21 2025-03-31 13F/A-1 CYTOKINETICS COM NEW 23282W605 1,722,984 1,553,071 914.04 69,247 766.44 0.1581
2025-05-15 2025-03-31 13F CYTOKINETICS COM NEW 23282W605 1,722,984 1,553,071 69,247 0.1581
2025-02-14 2024-12-31 13F CYTOKINETICS COM NEW 23282W605 169,913 -294,097 -63.38 7,993 -67.38 0.0176
2024-11-14 2024-09-30 13F CYTOKINETICS COM NEW 23282W605 464,010 89,162 23.79 24,500 20.63 0.0623
2024-09-16 2024-06-30 13F/A-2 CYTOKINETICS COM NEW 23282W605 374,848 10,139 2.78 20,309 -20.57 0.0531
2024-08-19 2024-06-30 13F/A-1 CYTOKINETICS COM NEW 23282W605 374,848 10,139 20,309 0.0531
2024-08-14 2024-06-30 13F CYTOKINETICS COM NEW 23282W605 374,848 10,139 20,309 0.0531
2024-05-15 2024-03-31 13F CYTOKINETICS COM NEW 23282W605 364,709 207,609 132.15 25,570 94.95 0.0620
2024-02-14 2023-12-31 13F CYTOKINETICS COM NEW 23282W605 157,100 157,100 13,116 0.0317
2023-11-14 2023-09-30 13F CYTOKINETICS COM NEW 23282W605 0 -160,400 -100.00 0 -100.00
2023-08-14 2023-06-30 13F CYTOKINETICS COM NEW 23282W605 160,400 160,400 5,232 0.0156
2023-05-15 2023-03-31 13F CYTOKINETICS COM NEW 23282W605 0 -271,500 -100.00 0 -100.00
2023-05-15 2022-12-31 13F/A-1 CYTOKINETICS COM NEW 23282W605 271,500 239,500 748.44 12,440 702.58 0.0423
2023-02-14 2022-12-31 13F CYTOKINETICS COM NEW 23282W605 271,500 239,500 12,440 0.0423
2022-11-14 2022-09-30 13F CYTOKINETICS COM NEW 23282W605 32,000 12,367 62.99 1,550 101.04 0.0062
2022-08-15 2022-06-30 13F CYTOKINETICS COM NEW 23282W605 19,633 -1,602,967 -98.79 771 -98.71 0.0033
2022-05-16 2022-03-31 13F CYTOKINETICS COM NEW 23282W605 1,622,600 737,146 83.25 59,728 47.99 0.2371
2022-02-14 2021-12-31 13F CYTOKINETICS COM NEW 23282W605 885,454 -123,846 -12.27 40,359 11.88 0.1612
2021-11-15 2021-09-30 13F CYTOKINETICS COM NEW 23282W605 1,009,300 681,800 208.18 36,072 456.58 0.1584
2021-08-16 2021-06-30 13F CYTOKINETICS COM NEW 23282W605 327,500 -47,100 -12.57 6,481 -25.62 0.0291
2021-05-17 2021-03-31 13F CYTOKINETICS COM NEW 23282W605 374,600 -791,694 -67.88 8,713 -64.05 0.0407
2021-02-16 2020-12-31 13F CYTOKINETICS COM NEW 23282W605 1,166,294 -440,056 -27.39 24,236 -30.31 0.1182
2020-11-16 2020-09-30 13F CYTOKINETICS COM NEW 23282W605 1,606,350 1,278,073 389.33 34,777 349.49 0.1781
2020-08-14 2020-06-30 13F CYTOKINETICS COM NEW 23282W605 328,277 -462,923 -58.51 7,737 -17.06 0.0505
2020-05-15 2020-03-31 13F CYTOKINETICS COM NEW 23282W605 791,200 -2,237,551 -73.88 9,328 -70.97 0.0758
2020-02-14 2019-12-31 13F CYTOKINETICS COM NEW 23282W605 3,028,751 2,594,651 597.71 32,135 550.51 0.1690
2019-11-15 2019-09-30 13F CYTOKINETICS COM NEW 23282W605 434,100 -172,900 -28.48 4,940 -27.66 0.0303
2019-08-14 2019-06-30 13F CYTOKINETICS COM NEW 23282W605 607,000 607,000 6,829 0.0357
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F CYTOKINETICS COM NEW Call 28,000 7.28 1,845 11.28 n/a n/a n/a
2026-02-17 2025-12-31 13F CYTOKINETICS COM NEW Call 26,100 30.50 1,658 50.86 n/a n/a n/a
2025-11-14 2025-09-30 13F CYTOKINETICS COM NEW Call 20,000 1,099 n/a n/a n/a
2025-07-21 2025-03-31 13F/A CYTOKINETICS COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F CYTOKINETICS COM NEW Call 0 0 n/a n/a n/a
2025-02-14 2024-12-31 13F CYTOKINETICS COM NEW Call 100,000 400.00 4,704 345.45 n/a n/a n/a
2024-11-14 2024-09-30 13F CYTOKINETICS COM NEW Call 20,000 0.00 1,056 -2.49 n/a n/a n/a
2024-08-19 2024-06-30 13F/A CYTOKINETICS COM NEW Call 20,000 1,084 n/a n/a n/a
2024-09-16 2024-06-30 13F/A CYTOKINETICS COM NEW Call 20,000 -57.89 1,084 -67.48 n/a n/a n/a
2024-08-14 2024-06-30 13F CYTOKINETICS COM NEW Call 20,000 1,084 n/a n/a n/a
2024-05-15 2024-03-31 13F CYTOKINETICS COM NEW Call 47,500 -90.50 3,330 -92.02 n/a n/a n/a
2024-02-14 2023-12-31 13F CYTOKINETICS COM NEW Call 500,000 41,745 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F CYTOKINETICS COM NEW Put 6,900 -37.84 455 -35.60 n/a n/a n/a
2026-02-17 2025-12-31 13F CYTOKINETICS COM NEW Put 11,100 -63.00 705 -57.22 n/a n/a n/a
2025-11-14 2025-09-30 13F CYTOKINETICS COM NEW Put 30,000 -45.45 1,649 -9.30 n/a n/a n/a
2025-08-14 2025-06-30 13F CYTOKINETICS COM NEW Put 55,000 1,817 n/a n/a n/a
2025-02-14 2024-12-31 13F CYTOKINETICS COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F CYTOKINETICS COM NEW Put 40,000 100.00 2,112 95.01 n/a n/a n/a
2024-08-19 2024-06-30 13F/A CYTOKINETICS COM NEW Put 20,000 1,084 n/a n/a n/a
2024-09-16 2024-06-30 13F/A CYTOKINETICS COM NEW Put 20,000 1,084 n/a n/a n/a
2024-08-14 2024-06-30 13F CYTOKINETICS COM NEW Put 20,000 1,084 n/a n/a n/a
2024-05-15 2024-03-31 13F CYTOKINETICS COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F CYTOKINETICS COM NEW Put 220,000 450.00 18,368 1,459.17 n/a n/a n/a
2023-11-14 2023-09-30 13F CYTOKINETICS COM NEW Put 40,000 1,178 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.